Stereoselective Metabolism of Bupropion to OH-bupropion, Threohydrobupropion, Erythrohydrobupropion, and 4′-OH-bupropion in vitro

por Sager, Jennifer E., Price, Lauren S. L., Isoherranen, Nina
Publicado 2016

Fluoxetine and norfluoxetine mediated complex drug-drug interactions: in vitro to in vivo correlation of effects on CYP2D6, CYP2C19 and CYP3A4

por Sager, Jennifer E, Lutz, Justin D, Foti, Robert S, Davis, Connie, Kunze, Kent L, Isoherranen, Nina
Publicado 2014

Age- and calorie-independent life span extension from dietary restriction by bacterial deprivation in Caenorhabditis elegans

por Smith, Erica D, Kaeberlein, Tammi L, Lydum, Brynn T, Sager, Jennifer, Welton, K Linnea, Kennedy, Brian K, Kaeberlein, Matt
Publicado 2008

Reduced body weight at weaning followed by increased post-weaning growth rate interacts with part-per-trillion fetal serum concentrations of bisphenol A (BPA) to impair glucose tol...

por Taylor, Julia A., Sommerfeld-Sager, Jennifer M., Meng, Chun-Xia, Nagel, Susan C., Shioda, Toshi, vom Saal, Frederick S.
Publicado 2018

Estrogen receptor 1 expression and methylation of Esr1 promoter in mouse fetal prostate mesenchymal cells induced by gestational exposure to bisphenol A or ethinylestradiol

por Bhandari, Ramji K, Taylor, Julia A, Sommerfeld-Sager, Jennifer, Tillitt, Donald E, Ricke, William A, vom Saal, Frederick S
Publicado 2019

631. Preliminary safety and pharmacokinetic profile of VIR-2482: a monoclonal antibody for the prevention of influenza A illness

por Sager, Jennifer, Hong, David K, Bonavia, Aurelio, Connolly, Lynn, Cebrik, Deborah, Fanget, Marie Christine, Mogalian, Erik, Griffin, Paul
Publicado 2020

Population pharmacokinetics and exposure‐response analysis of a single dose of sotrovimab in the early treatment of patients with mild to moderate COVID‐19

por Sager, Jennifer E., El‐Zailik, Asma, Passarell, Julie, Roepcke, Stefan, Li, Xiaobin, Aldinger, Melissa, Nader, Ahmed, Skingsley, Andrew, Alexander, Elizabeth L., Yeh, Wendy W., Mogalian, Erik, Garner, Chad, Peppercorn, Amanda, Shapiro, Adrienne E., Reyes, Maribel
Publicado 2023

Safety, Virology, Pharmacokinetics, and Clinical Experience of High-Dose Intravenous Sotrovimab for the Treatment of Mild to Moderate COVID-19: An Open-Label Clinical Trial

por Moya, Jaynier, Temech, Marisol, Parra, Sergio, Juarez, Erick, Hernandez-Loy, Reinaldo, Gutierrez, Juan C Moises, Diaz, Jorge, Hussain, Rubaba, Segal, Scott, Xu, Claire, Skingsley, Andrew, Schnell, Gretja, El-Zailik, Asma, Sager, Jennifer E, Aldinger, Melissa, Alexander, Elizabeth L, Acloque, Gerard
Publicado 2023

502. Early COVID-19 Treatment with SARS-CoV-2 Neutralizing Antibody Sotrovimab

por Gupta, Anil K, Rojas, Yaneicy Gonzalez, Juarez, Erick, Casal, Manuel Crespo, Moya, Jaynier, Falci, Diego Rodrigues, Sarkis, Elias H, Solis, Joel, Zheng, Hanzhe, Scott, Nicola, Cathcart, Andrea L, Hebner, Christy, Sager, Jennifer, Mogalian, Erik, Austin, Daren, Peppercorn, Amanda, Alexander, Elizabeth L, Yeh, Wendy W, Free, Almena, Brinson, Cynthia, Aldinger, Melissa, Shapiro, Adrienne
Publicado 2021

Intramuscular vs Intravenous SARS-CoV-2 Neutralizing Antibody Sotrovimab for Treatment of COVID-19 (COMET-TAIL): A Randomized Noninferiority Clinical Trial

por Shapiro, Adrienne E, Sarkis, Elias, Acloque, Jude, Free, Almena, Gonzalez-Rojas, Yaneicy, Hussain, Rubaba, Juarez, Erick, Moya, Jaynier, Parikh, Naval, Inman, David, Cebrik, Deborah, Nader, Ahmed, Noormohamed, Nadia, Wang, Qianwen, Skingsley, Andrew, Austin, Daren, Peppercorn, Amanda, Agostini, Maria L, Parra, Sergio, Chow, Sophia, Mogalian, Erik, Pang, Phillip S, Hong, David K, Sager, Jennifer E, Yeh, Wendy W, Alexander, Elizabeth L, Gaffney, Leah A, Kohli, Anita
Publicado 2023